Newscrate logo

Browse the latest pfizer inc news online for free

Search results for "pfizer inc"

Europe Subcutaneous Immunoglobulin Market Growing Trends and Demands Analysis Forecast 2025 to 2034 | Pfizer Inc., Kedrion S.p.A, Biotest AG
Europe Subcutaneous Immunoglobulin Market Growing Trends and Demands Analysis Forecast 2025 to 2034 | Pfizer Inc., Kedrion S.p.A, Biotest AG

Market Size and Share:Europe Subcutaneous Immunoglobulin Market is currently valued at USD 2.5 Billion in 2024 and is anticipated to generate an estimated revenue of USD 5.9 Billion by 2034, according to the latest study by Polaris Market Research. Besides, Read more

Openpr.com - Nov 18
Advisors Capital Management LLC Acquires 621,654 Shares of Pfizer Inc. $PFE
Advisors Capital Management LLC Acquires 621,654 Shares of Pfizer Inc. $PFE

Advisors Capital Management LLC boosted its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 40.7% during the 2nd quarter, Holdings Channel.com reports. The fund owned 2,150,721 shares of the biopharmaceutical company’s stock after purchasing an additional 621,654 shares during the quarter. Ad... Read more

Americanbankingnews - Nov 14
Fatty Acid Oxidation Disorder Drugs Market is expected to reach US$ 13.99 billion by 2029 | Top Companies - Pfizer Inc., Action Labs, Lonza Group Ltd.
Fatty Acid Oxidation Disorder Drugs Market is expected to reach US$ 13.99 billion by 2029 | Top Companies - Pfizer Inc., Action Labs, Lonza Group Ltd.

Market Size and Growth:The Global Fatty Acid Oxidation Disorder Drugs Market Size reached US$ 9.55 billion in 2024 and is expected to reach US$ 13.99 billion by 2029, growing with a CAGR of 8.1% during the forecast period 2024-2029. The Read more

Openpr.com - Nov 10
Herpes Zoster Oticus Market is expected to reach US$ 36.9 million by 2032 | Major key players - GSK plc., Pfizer Inc., Apotex Inc.
Herpes Zoster Oticus Market is expected to reach US$ 36.9 million by 2032 | Major key players - GSK plc., Pfizer Inc., Apotex Inc.

Market Size and Growth:The Global Herpes Zoster Oticus Market Size reached US$ 12.3 million in 2024 and is expected to reach US$ 36.9 million by 2032, growing at a CAGR of 13.2% during the forecast period 2024-2032. The Market is Read more

Openpr.com - Nov 10
Central Nervous System Disorders Therapeutics Market to Expand Rapidly Over Next Decade | Biogen Inc., Pfizer Inc., Eli Lilly and Company
Central Nervous System Disorders Therapeutics Market to Expand Rapidly Over Next Decade | Biogen Inc., Pfizer Inc., Eli Lilly and Company

The Central Nervous System Disorders Therapeutics market is estimated to be valued at USD 97,028.1 Mn in 2025 and is expected to reach USD 159,583.2 Mn by 2032, growing at a compound annual growth rate CAGR of 7.4% from 2025 Read more

Openpr.com - Nov 05
Immunodeficiency Therapeutics Market Is Booming So Rapidly Growth by 2032| Pfizer Inc., CSL Behring, Grifols
Immunodeficiency Therapeutics Market Is Booming So Rapidly Growth by 2032| Pfizer Inc., CSL Behring, Grifols

The Immunodeficiency Therapeutics market is estimated to be valued at USD 6,991.1 Mn in 2025 and is expected to reach USD 10,581.6 Mn by 2032, growing at a compound annual growth rate CAGR of 6.1% from 2025 to 2032.➤ The Read more

Openpr.com - Nov 05
Non-PVC IV Bags Market Poised for Rapid Explosive Growth| Baxter International Inc., B. Braun Melsungen AG, and Pfizer Inc. Hospira
Non-PVC IV Bags Market Poised for Rapid Explosive Growth| Baxter International Inc., B. Braun Melsungen AG, and Pfizer Inc. Hospira

The Non-PVC IV Bags market is estimated to be valued at USD 2.44 Bn in 2025 and is expected to reach USD 4.96 Bn by 2032, growing at a compound annual growth rate CAGR of 10.7% from 2025 to 2032.➤ Read more

Openpr.com - Nov 04